Bibliografía del artículo
1. Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R et al. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc 37(7):3045-7, 2006.
2. Pereira BJG. Hepatitis C infection and post-transplantation liver disease. Nephrol Dial Transplant 10(Supl 1):58-67, 2005.
3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346:580-90 , 2002.
4. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney Int 73(Suppl 109):S53-S68, 2008.
5. Fabrizi F, Martín P, Ponticelli C. Hepatitis C virus infection and renal transplantation Am J Kid Dis 38:919-34, 2009.
6. Morales JM, Campistol JM, Andres A, Rodicio JL. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens 6:511-5, 2002.
7. Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 69(3):149-60, 2008.
8. Morales JM, Campistol JM, Andres A, Rodicio JL. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens 6:511-5, 1997.
9. Ortega RJ. Rev Col Gastroenterología 20:32-42, 2007.
10. Pereira BJ, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325:454-60, 2006.
11. Australian and New Zealand Dialysis and Transplant Registry Twenty Third Report 2009.
12. Conway M, Catterall A, Brown E, et al. Prevalence of anti-bodies to HCV in dialysis patients and transplant recipients with possible routes of transmission. Neph Dial Transplant 7:1226, 2011.
13. Base de Datos. Servicio de Nefrología. Hospital Universitario Manuel Ascunce Domenech. Camagüey, Cuba, 2011.
14. De Armas Bada JL, Comportamiento de la hepatitis C en el Servicio de Hemodiálisis de Camagüey. Trabajo de Terminación de la Especialidad para Optar por el Título de Especialista de Primer Grado en Nefrología, 2008.
15. Domínguez-Gil B, Esforzado N, Campistol JM, Andres A, Morales JM. Use of hepatitis C-positive donors for kidney transplantation. Transplant Rev 21:195-203, 2007.
16. Diego JM, Roth D. Treatment of hepatitis C infection in patients with renal disease. Curr OpinNephrol Hypertens 7:557-82, 2010.
17. Abbott KC, Bucci JR, Matsumoto CS, Swanson SJ, Agodoa LY, Holtzmuller KC, et al. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 14:2908-18, 2003.
18. Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, et al. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German ata. Transplant Proc 40:909-14 , 2008.
19. Herbert L, Bonkovsky MD, Savant Mehta MD. Hepatitis C: A review and update. Journal of the American Academy of Dermatology 44(2), 2001.
20. Maluf DG, Fisher RA, King AL, Gibney EM, Mas VR, Cotterell AH, et al. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 83:853-7, 2007.
21. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 29:257-63, 2009.
22. Pol S, Samuel D, Cadranel JF et al. Hepatitis and solid organ transplantation (review). Transplant Proc 32:454-7, 2000.
23. Mizrai R. Donante marginal renal. Riñón apto para trasplante. XIII Congreso Latinoamericano de Nefrología 2(1), 2004.
24. Oreopoulus DG, Dialyzing the elderly benefit of burden. Nefrologia 17(Sup 3):S2-S8, 1997.
25. Jassal SV, Olpez G, Cole E. Transplantation on the elderly. A review. Geriatric Nephrol Urol 7:157-165, 1997.
26. Lagoa MR. Simposio sobre patología del trasplante: grupo Banff. [Fecha de acceso 14 de noviembre de 2003] URL disponible en: http://www.diariomedico.com.
27. Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74:427-37, 2010.
28. Pérez JL, Pumarola T. The microbiology laboratory: A key participant in transplantation. Enferm Infecc Microbiol Clin 25(4):270-84, 2007.
29. Organización Nacional de Trasplantes. Documentos de consenso. Criterios de selección de donante de órganos respecto a la transmisión de infecciones. 2ª Edición. Noviembre 2004. Disponible en http://www.ont.es/Consenso?id_nodo=263&accion=0&accion=0&keyword=&auditoria=F.
30. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: possible association with hepatitis C. Transplant Proc 38(9):2989-92, 2006.
31. Gavela E, Crespo JF, Sancho A, Avila A. Diabetes Mellitus postrasplante asociada a la hepatitis por virus C en el trasplante renal. Nefrología 24(1):7-8, 2004.
32. Borroto Díaz G et al. Impacto del virus de la hepatitis C en las complicaciones inmediatas y los trastornos metabólicos glucémicos del trasplante renal. Rev Cubana Med 47(4), 2008.
33. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185, 2003.
34. López R, Gentil MA. Minimal model analysis in nondiabetic renal transplant recipients with hepatits C. Transplant Proc 37(3):1446-8, 2005.
35. Roland M, Gatault P, Al-Najjar A, et al. Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant 8:1719-28, 2008.
36. Porrini E, Moreno JM, Osuna A, et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. Transplantation 85(8):1133-8, 2008.
37. Reddy KS, Stablein D, Taranto S, et al. Long term survival following simultaneous kidney-pancreas transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 41:464-470, 2003.
38. Montori VM, Basu A, Erwin P, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25:583-592, 2002.
39. Melin J, Hellberg O, Larsson E, Zezina L, Fellström B. Protective effect of insulin on ischemic renal injury in diabetes mellitus. Kidney Int 61:1383-1392, 2009.
40. Wyzgal J, Paczek L, Ziolkowski J, et al. Early hyperglycemia after allogenic kidney transplantation. Ann Transplant 12(1):40-5, 2007.
41. Porrini E, Delgado P, Álvarez A, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transplant 23(4):1436-41, 2003.
42. Bayés B, Granada ML, Pastor MC, et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant 7(2):416-22, 2007.
43. Porrini E, Delgado P, Bigo C, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 48(1):134-42, 2006.
44. Pouteil-Noble C, Tardy JC, Chossegros P, Mion F, Chevallier M, Gerard F, Chevallier P, Megas F, Lefrancois N, Touraine JL; Co-infection by hepatitis B and hepatitis C virus in renal transplantation: morbidity and mortality in 1.098 patients. Nephrol Dial Transplant 10 (suppl 6):122-124, 2009.
45. Roth D, Zucker K, Cirocco R, De Mattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45:238-244, 2008.
46. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 38(5):919-34, 2001.
47. Hernández D, Campistol JM, Rufino M, et al. Spanish Late Allograft Dysfunction Study Group. A novel risk score for mortality in renal transplant recipients be-yond the first posttransplant year. Transplantation 88:803-9, 2009.
48. Hernandez D, Rufino M, Bartolomei S, Torres A, et al. A novel prognostic index for mortality in renal transplant recipients after hospitalization. Transplantation 79:337-43, 2005.
49. Sayegh M, Carpenter C. Transplantation 50 years later progress, challenges, and promises. N Engl J Med 351(26): 761-2766, 2004.
50. Mármol A. Eras de inmunosupresión. Décima Ley. Trasplante renal y enfermedad renal crónica, sistema de leyes integradoras, Editorial Ciencias Médicas, pp. 116-121, 2009.
51. Grande JP, Cosio FG. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 9:2800-7, 2009.
52. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8:753-60, 2008.
53. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123:615-620, 1995.
54. Aalten J, Hoogeven EK, Roodnat JL et al. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 21:985-91, 2008.
55. Díaz Gómez JM, Impacto de los factores de riesgo cardiovasculares en el paciente trasplantado renal. Universidad Autónoma de Barcelona, 2008.
56. Lacombe M. Arterial complications after renal transplantation. Bull Acad Natl Med 188(5):767-78, 2004.
57. Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ. Reduction in cardiovascular death after kidney transplantation. Transplantation 89:851-857, 2010.
58. Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomized controlled trials. BMJ 336:645-51, 2008.
59. Roth D: Hepatitis C virus: the nephrologists view. Am J Kid Dis 25:3-16, 2009.
60. Laquaglia MP, Tolkoff-Rubin NE, Deinstag JL y cols: Impact of hepatitis on renal transplantation. Transplantation 32:504-507, 2008.
61. Singh N, Goyowski T, Wagener MM, Marino IR: Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 61:402-406, 2009.
62. Rao KV, Ma. J: Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 62:1765-1769, 2009.
63. Morris P, Johnson R, Fuggle S, Belger M, Briggs J; on behalf of the HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 354:1147-1152, 1999.
64. Morales JM. Renal transplantation in patients positive for hepatitis B or C (pro). Transplant Proc 30:2070-2, 2010.
65. Berthoux F; on behalf The European Expert Group for Renal Transplantation. The European Best Practice Guidelines for renal transplantation (part I). Nephrol Dial Transplant 15(suppl 7):1-85, 2009.
66. Rodrigo E, Miñambres E, Ruiz JC, et al. Prediction of delayed graft function by means of a novel web-based calculator: a single-center experience. Am J Transplant 12:240-4, 2012.
67. Kasiske BL, Israni AK, Snyder JJ, Skeans MA. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 57:466-75, 2011.
68. Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJC, Stock PG, Meltzer JS, Vincenti F. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplant 9:119-124, 1995.
69. Alivanis P, Derveniotis V, Dioudis C, Grekas D, Mandravelli P, Vasiliou S, Tourkantonis A: Hepatitis C virus antibodies in hemodialysed and in renal transplant patients: Correlation with chronic liver disease. Transplant Proc 23:2662-2663, 2008.
70. Lau JYN, Davis GL, Brunson ME, Qian KP, Kin HJ, Quan S, Dinello R, Polito AJ, Scornik JC: Hepatitis C virus infection in kidney transplant recipients. Hepatology 18:1027-1031, 2008.
71. Kliem V, Van den Hoff U, Brunkhorst R, Tillmann HL, Flik J, Manns MP, Pichlmayer R, Koch KM, Frei U. The long-term course of hepatitis C after kidney transplantation. Transplantation 62:1417-1421, 2010.
72. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ, The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients. Am J Kid Dis 29(4):608-614, 2004.
73. Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325:454-460, 2001.
74. Bouthot BE, Murthy BVR, Schmid H, Levey AS, Pereira BJG. Long-term follow-up of hepatitis C virus infection among organ transplanted recipients. Implications for policies on organ procurement. Transplantation 63:849-853, 2006.
75. Morales JM, Corell A, Muñoz MA, Gota R, Muñoz de Bustillo E, Andrés A, Fuertes A. Renal transplant patients with HCV infection have less rejection and excellent survival figures with a less aggressive immunosuppressive protocol in spite of a higher incidence of severe infections. ASTP Congress, Chicago 2007; p 121 (abstract).